PULMOTECT, INC

Harnessing the Power of the Innate Immune System

Houston, United States · Founded 2015 · $32.0M raised

Headquarters
Houston, Texas
Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$32.0M
Last Round
$5.9M Series CSep 2024
Rounds
6

About

Pulmotect is a clinical-stage biopharmaceutical company harnessing the innate immune system to prevent and treat respiratory infections. Its lead product, PUL-042, is an inhaled therapeutic that activates lung innate immunity, protecting against bacterial, fungal, and viral pathogens, with a focus on immunocompromised oncology patients.

Summary

PULMOTECT, INC is a Biotech company based in Houston, United States, founded in 2015. It has raised $32.0M in total across 6 rounds, most recently a $5.9M Series C round in Sep 2024. Investors include Cancer Prevention and Research Institute of Texas, Fannin Partners LP (internal fund) and U.S. Department of Defense.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CSep 2024
$5.9M

Sign up to see all 6 rounds

Grant through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

PULMOTECT, INC on Indexed.vc
<a href="https://indexed.vc/companies/pulmotect-inc"><img src="https://indexed.vc/api/badge/company/pulmotect-inc" alt="PULMOTECT, INC on Indexed.vc" width="260" height="76" /></a>